Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma

Name: Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma
Published: 2023
License: Public Domain

Duke University · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

distress multiple-myeloma ophthalmology patient-reported-outcomes

multiple myeloma, relapsed, refractory, ophthalmology, keratopathy, distress, national comprehensive cancer network (nccn) distress thermometer, retrospective, patient reported outcomes, belantamab mafodotin, blenrep, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma

Related documents